Related Experiment Video
Updated: Jun 5, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Relapse of Enterococcus hirae prosthetic valve endocarditis.
J P Talarmin1, S Pineau, A Guillouzouic
1CHU de Nantes, Service des Maladies Infectieuses et Tropicales, 44093 Nantes Cedex 1, France.
A rare gram-positive bacterium, Enterococcus hirae, caused a prosthetic valve endocarditis relapse 6 months after the first episode. Genomic analysis confirmed the clonal relationship between the initial and recurrent infections.
Area of Science:
- Infectious Diseases
- Microbiology
- Genomics
Background:
- Enterococcus hirae is a gram-positive bacterium infrequently identified in clinical settings.
- Prosthetic valve endocarditis (PVE) is a serious infection requiring prompt diagnosis and treatment.
Observation:
- This report details a rare case of recurrent PVE caused by Enterococcus hirae.
- The relapse occurred 6 months following the initial PVE episode.
Findings:
- Genomic analysis provided definitive proof of a clonal relationship between the initial and relapsed E. hirae infections.
- This finding highlights the potential for persistent or relapsing infections with this uncommon pathogen.
Implications:
- Understanding the genomic relatedness of recurrent pathogens is crucial for effective treatment strategies.
- This case underscores the importance of considering Enterococcus hirae in recurrent or persistent PVE, even if initially rare.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Mitral Stenosis III: Medical Management
